Results 91 to 100 of about 1,239 (147)

Infigratinib low dose therapy is an effective strategy to treat hypochondroplasia. [PDF]

open access: yesJ Bone Miner Res
Demuynck B   +9 more
europepmc   +1 more source

Achondroplasia management in the era of targeted therapies: a meta-analysis of C-type natriuretic peptide analogs. [PDF]

open access: yesJ Endocr Soc
Kamrul-Hasan ABM   +6 more
europepmc   +1 more source

Evidence-based classification of genes implicated in skeletal disorders using the ClinGen curation framework. [PDF]

open access: yesJ Bone Miner Res
Webb RF   +27 more
europepmc   +1 more source

O03: Vosoritide increases growth velocity in hypochondroplasia: Phase 2 trial results

open access: yesGenetics in Medicine Open
Andrew Dauber   +9 more
doaj   +1 more source

A phase II basket trial of vosoritide in children with RASopathies, ACAN, and NPR2 deficiency.

open access: yesJ Clin Endocrinol Metab
Dauber A   +7 more
europepmc   +1 more source

P368: Design of the ACCEL study: A prospective clinical assessment study in children with hypochondroplasia

open access: yesGenetics in Medicine Open
Ravi Savarirayan   +5 more
doaj   +1 more source

Brachydactyly Type A1 Caused by an <i>IHH</i> Variant in a Patient with Disproportionate Short Stature: A Case Report. [PDF]

open access: yesReports (MDPI)
García de Pablo I   +4 more
europepmc   +1 more source

Home - About - Disclaimer - Privacy